Aehr Test Systems (AEHR)
(Real Time Quote from BATS)
$13.05 USD
-0.08 (-0.61%)
Updated Sep 27, 2024 12:16 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Income Statements
Fiscal Year end for Aehr Test Systems falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | |
---|---|---|---|---|---|
Sales | 66 | 65 | 51 | 17 | 22 |
Cost Of Goods | 34 | 32 | 27 | 11 | 14 |
Gross Profit | 33 | 33 | 24 | 6 | 8 |
Selling & Adminstrative & Depr. & Amort Expenses | 22 | 19 | 16 | 10 | 11 |
Income After Depreciation & Amortization | 10 | 13 | 8 | -4 | -3 |
Non-Operating Income | 2 | 0 | 2 | 2 | 0 |
Interest Expense | 0 | -1 | 0 | 0 | 0 |
Pretax Income | 12 | 15 | 10 | -2 | -3 |
Income Taxes | -21 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 33 | 15 | 9 | -2 | -3 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 33 | 15 | 9 | -2 | -3 |
Depreciation Footnote | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11 | 14 | 8 | -4 | -2 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 10 | 13 | 8 | -4 | -3 |
Earnings Per Share Data | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Average Shares | 29.62 | 29.22 | 27.77 | 23.46 | 22.88 |
Diluted EPS Before Non-Recurring Items | 1.12 | 0.50 | 0.32 | -0.19 | -0.04 |
Diluted Net EPS (GAAP) | 1.12 | 0.50 | 0.34 | -0.09 | -0.12 |
Fiscal Year end for Aehr Test Systems falls in the month of May .
All items in Millions except EPS data.
8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | |
---|---|---|---|---|---|
Sales | NA | 16.60 | 7.56 | 21.43 | 20.62 |
Cost Of Goods | NA | 8.15 | 4.41 | 10.47 | 10.64 |
Gross Profit | NA | 8.45 | 3.16 | 10.96 | 9.98 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.91 | 5.20 | 5.49 | 5.87 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.54 | -2.04 | 5.47 | 4.11 |
Non-Operating Income | NA | 0.58 | 0.58 | 0.64 | 0.58 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 3.12 | -1.46 | 6.11 | 4.69 |
Income Taxes | NA | -20.74 | 0.01 | 0.02 | 0.02 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 23.86 | -1.47 | 6.09 | 4.67 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 23.86 | -1.47 | 6.09 | 4.67 |
Earnings Per Share Data | 8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 29.46 | 28.87 | 29.77 | 29.63 |
Diluted EPS Before Non-Recurring Items | NA | 0.81 | -0.05 | 0.20 | 0.16 |
Diluted Net EPS (GAAP) | NA | 0.81 | -0.05 | 0.20 | 0.16 |